169 related articles for article (PubMed ID: 23866835)
21. Clinical efficacy and safety of Chinese herbal medicine for the treatment of patients with early diabetic nephropathy: A protocol for systematic review and meta-analysis.
Yang X; Hu C; Wang S; Chen Q
Medicine (Baltimore); 2020 Jul; 99(29):e20678. PubMed ID: 32702818
[TBL] [Abstract][Full Text] [Related]
22. Treatment of hospital-acquired pneumonia with multi-drug resistant organism by Buzhong Yiqi decoction based on Fuzheng Quxie classical prescription: study protocol for a randomized controlled trial.
Deng D; Chen Z; Jia L; Bu J; Ye M; Sun L; Gen Y; Zhang W; Chen G; Fang B
Trials; 2019 Dec; 20(1):817. PubMed ID: 31888702
[TBL] [Abstract][Full Text] [Related]
23. A cluster randomized trial of an enhanced eGFR prompt in chronic kidney disease.
Manns B; Tonelli M; Culleton B; Faris P; McLaughlin K; Chin R; Gooch K; McAlister FA; Taub K; Thorlacius L; Krause R; Kearns M; Hemmelgarn B;
Clin J Am Soc Nephrol; 2012 Apr; 7(4):565-72. PubMed ID: 22344504
[TBL] [Abstract][Full Text] [Related]
24. A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy.
Bauer JH; Reams GP; Hewett J; Klachko D; Lau A; Messina C; Knaus V
Am J Kidney Dis; 1992 Nov; 20(5):443-57. PubMed ID: 1442757
[TBL] [Abstract][Full Text] [Related]
25. Add-on astragalus in type 2 diabetes and chronic kidney disease: A multi-center, assessor-blind, randomized controlled trial.
Chan KW; Kwong ASK; Tsui PN; Chan GCW; Choi WF; Yiu WH; Cheung SCY; Wong MMY; Zhang ZJ; Tan KCB; Lao L; Lai KN; Tang SCW;
Phytomedicine; 2024 Jul; 130():155457. PubMed ID: 38810556
[TBL] [Abstract][Full Text] [Related]
26. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
Lewis EJ; Lewis JB
Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
[TBL] [Abstract][Full Text] [Related]
27. Comparison of intrarenal renin-angiotensin system activity in diabetic versus non-diabetic patients with overt proteinuria.
Park JH; Jang HR; Lee JH; Lee JE; Huh W; Lee KB; Kwon YJ; Do JY; Kim HY; Kim YG
Nephrology (Carlton); 2015 Apr; 20(4):279-85. PubMed ID: 25522682
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic Role of Tangshenkang Granule () in Rat Model with Diabetic Nephropathy.
Hu SJ; Shu B; Jin H; Li XF; Mao JR; Ren KJ; Gao L; Yang L; Wu YW; Wang YJ
Chin J Integr Med; 2018 Aug; 24(8):600-605. PubMed ID: 27778266
[TBL] [Abstract][Full Text] [Related]
29. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
Ivory SE; Packham DK; Reutens AT; Wolfe R; Rohde RD; Lewis J; Atkins RC;
Nephrology (Carlton); 2013 Jul; 18(7):516-24. PubMed ID: 23506627
[TBL] [Abstract][Full Text] [Related]
30. Traditional Chinese medicine for stable angina pectoris via TCM pattern differentiation and TCM mechanism: study protocol of a randomized controlled trial.
Zhang Z; Zhang F; Wang Y; Du Y; Zhang H; Kong D; Liu Y; Yang G
Trials; 2014 Oct; 15():422. PubMed ID: 25359307
[TBL] [Abstract][Full Text] [Related]
31. Acupuncture paired with herbal medicine for prediabetes: study protocol for a randomized controlled trial.
Li X; Liu H; Feng H; Xian Z; Chen Y; Chen J; Tang C; Lai X; Lan X; Huang H; Yu D
Trials; 2017 Jun; 18(1):297. PubMed ID: 28659162
[TBL] [Abstract][Full Text] [Related]
32. Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial.
Fallahzadeh MK; Dormanesh B; Sagheb MM; Roozbeh J; Vessal G; Pakfetrat M; Daneshbod Y; Kamali-Sarvestani E; Lankarani KB
Am J Kidney Dis; 2012 Dec; 60(6):896-903. PubMed ID: 22770926
[TBL] [Abstract][Full Text] [Related]
33. Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA
Rosenstock J; Perkovic V; Alexander JH; Cooper ME; Marx N; Pencina MJ; Toto RD; Wanner C; Zinman B; Baanstra D; Pfarr E; Mattheus M; Broedl UC; Woerle HJ; George JT; von Eynatten M; McGuire DK;
Cardiovasc Diabetol; 2018 Mar; 17(1):39. PubMed ID: 29540217
[TBL] [Abstract][Full Text] [Related]
34. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
Katavetin P; Eiam-Ong S; Suwanwalaikorn S
J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
[TBL] [Abstract][Full Text] [Related]
35. A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease.
Sinsakul M; Sika M; Rodby R; Middleton J; Shyr Y; Chen H; Han E; Lehrich R; Clyne S; Schulman G; Harris R; Lewis J
Am J Kidney Dis; 2007 Dec; 50(6):946-51. PubMed ID: 18037095
[TBL] [Abstract][Full Text] [Related]
36. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial.
Tan SMQ; Chiew Y; Ahmad B; Kadir KA
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30227659
[TBL] [Abstract][Full Text] [Related]
37. The efficacy and safety of Jian-Wei-Qu-Tong Pills for the treatment of chronic non-atrophic gastritis (spleen and stomach qi deficiency with damp-heat stasis syndrome): study protocol for a phase II, randomized controlled trial.
Zhang XX; Chen WW; She B; Luo RJ; Shi N; Xue P; Yang XN; Xia Q
Trials; 2014 Jul; 15():272. PubMed ID: 25002101
[TBL] [Abstract][Full Text] [Related]
38. Long-term effects of addition of mineralocorticoid receptor antagonist to angiotensin II receptor blocker in patients with diabetic nephropathy: a randomized clinical trial.
Esteghamati A; Noshad S; Jarrah S; Mousavizadeh M; Khoee SH; Nakhjavani M
Nephrol Dial Transplant; 2013 Nov; 28(11):2823-33. PubMed ID: 24009294
[TBL] [Abstract][Full Text] [Related]
39. [Effect of Chinese herbal medicine with Supplement Qi and Activating Blood Circulation on tubular reabsorption function of diabetic nephropathy rats].
Yin JJ; Yang Y; Wang QB; Li Y; Yin DK
Zhong Yao Cai; 2013 Jun; 36(6):953-8. PubMed ID: 24380284
[TBL] [Abstract][Full Text] [Related]
40. Traditional Chinese medicine in the treatment of idiopathic pulmonary fibrosis based on syndrome differentiation: Study protocol of an exploratory trial.
Yu XQ; Yang SG; Xie Y; Li JS
J Integr Med; 2020 Mar; 18(2):163-168. PubMed ID: 31928920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
